| Trial ID: | L0327 |
| Source ID: | NCT01406704
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NASH (Non-alcoholic Steato-hepatitis)
|
| Interventions: |
Drug: Rosiglitazone|Drug: alpha-lipoic acid|Drug: Rosiglitazone/alpha-lipoic acid
|
| Outcome Measures: |
Histological evaluation|Biomechanical measurement
|
| Sponsor/Collaborators: |
Seoul St. Mary's Hospital|GlaxoSmithKline
|
| Gender: |
All
|
| Age: |
20 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
26
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention
|
| Start Date: |
January 2004
|
| Completion Date: |
December 2013
|
| Results First Posted: |
--
|
| Last Update Posted: |
August 19, 2011
|
| Locations: |
--
|
| URL: |
https://ClinicalTrials.gov/show/NCT01406704
|
